Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +10.55% | +4.76% | -22.81% |
Business Summary
Number of employees: 102
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Production Project
90.4
%
| 14 | 89.6 % | 14 | 90.4 % | +1.56% |
Antibody Production Product
8.5
%
| 1 | 8.5 % | 1 | 8.5 % | -0.20% |
Cryostorage
1.2
%
| 0 | 1.8 % | 0 | 1.2 % | -36.11% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
45.7
%
| 8 | 48.7 % | 7 | 45.7 % | -5.42% |
United States
45.3
%
| 5 | 35.2 % | 7 | 45.3 % | +29.67% |
Australia
3.0
%
| 1 | 8.0 % | 0 | 3.0 % | -61.39% |
Canada
3.0
%
| 0 | 3.0 % | 0 | 3.0 % | +1.96% |
Other
2.9
%
| 1 | 5.2 % | 0 | 2.9 % | -43.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 18-02-20 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 23-09-28 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Frederick Chabot
IRC | Investor Relations Contact | - | - |
Barry Duplantis
PRN | Corporate Officer/Principal | - | - |
Kari Graber
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 23-09-04 |
Jennifer Bath
CEO | Chief Executive Officer | - | 18-02-20 |
Dirk Witters
BRD | Director/Board Member | - | 23-09-04 |
Barry Springer
BRD | Director/Board Member | - | 23-09-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,315,260 | 22,738,411 ( 86.41 %) | 0 | 86.41 % |
Company contact information
ImmunoPrecise Antibodies Ltd.
4464 Markham Street Suite 3204
V8Z 7X8, Victoria
+250-483-0308
http://www.immunoprecise.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 34.74M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- IPA Stock
- Company ImmunoPrecise Antibodies Ltd.